These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 23196275)
41. Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer. Cutz JC; Craddock KJ; Torlakovic E; Brandao G; Carter RF; Bigras G; Deschenes J; Izevbaye I; Xu Z; Greer W; Yatabe Y; Ionescu D; Karsan A; Jung S; Fraser RS; Blumenkrantz M; Lavoie J; Fortin F; Bojarski A; Côté GB; van den Berghe JA; Rashid-Kolvear F; Trotter M; Sekhon HS; Albadine R; Tran-Thanh D; Gorska I; Knoll JH; Xu J; Blencowe B; Iafrate AJ; Hwang DM; Pintilie M; Gaspo R; Couture C; Tsao MS J Thorac Oncol; 2014 Sep; 9(9):1255-63. PubMed ID: 25122422 [TBL] [Abstract][Full Text] [Related]
42. Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study. McLeer-Florin A; Moro-Sibilot D; Melis A; Salameire D; Lefebvre C; Ceccaldi F; de Fraipont F; Brambilla E; Lantuejoul S J Thorac Oncol; 2012 Feb; 7(2):348-54. PubMed ID: 22071784 [TBL] [Abstract][Full Text] [Related]
43. A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib. Thorne-Nuzzo T; Williams C; Catallini A; Clements J; Singh S; Amberson J; Dickinson K; Gatalica Z; Ho SN; Loftin I; McElhinny A; Towne P J Thorac Oncol; 2017 May; 12(5):804-813. PubMed ID: 28147239 [TBL] [Abstract][Full Text] [Related]
44. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations. Choi E; Williamson SR; Montironi R; Zhang S; Wang M; Eble JN; Grignon DJ; Lopez-Beltran A; Idrees MT; Baldridge LA; Scarpelli M; Jones CL; Wang L; MacLennan GT; Osunkoya AO; Cheng L Histopathology; 2015 Jul; 67(1):20-38. PubMed ID: 25406945 [TBL] [Abstract][Full Text] [Related]
45. Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing. Selinger C; Cooper W; Lum T; McNeil C; Morey A; Waring P; Amanuel B; Millward M; Peverall J; Van Vliet C; Christie M; Tran Y; Diakos C; Pavlakis N; Gill AJ; O'Toole S Histopathology; 2015 Nov; 67(5):654-63. PubMed ID: 25847523 [TBL] [Abstract][Full Text] [Related]
46. Detection of ALK-positive non-small-cell lung cancers on cytological specimens: high accuracy of immunocytochemistry with the 5A4 clone. Savic S; Bode B; Diebold J; Tosoni I; Barascud A; Baschiera B; Grilli B; Herzog M; Obermann E; Bubendorf L J Thorac Oncol; 2013 Aug; 8(8):1004-11. PubMed ID: 23689429 [TBL] [Abstract][Full Text] [Related]
47. Detection of ALK rearrangements in 4002 Russian patients: The utility of different diagnostic approaches. Demidova I; Grinevich V; Avdalian A; Imyanitov E; Gikalo M; Savelov N; Novikova I; Samuilenkova O; Tiurin V; Ulianova E; Tsimafeyeu I; Tjulandin S Lung Cancer; 2017 Jan; 103():17-23. PubMed ID: 28024691 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of D5F3 IHC for detecting ALK gene rearrangement in NSCLC patients: a systematic review and meta-analysis. Ma H; Yao WX; Huang L; Jin SH; Liu DH; Liu Y; Tian X; Tian JH; Zhou JG Oncotarget; 2016 Oct; 7(43):70128-70142. PubMed ID: 27602773 [TBL] [Abstract][Full Text] [Related]
49. A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material. Le Quesne J; Maurya M; Yancheva SG; O'Brien M; Popat S; Wotherspoon AC; de Castro DG; Nicholson AG J Thorac Oncol; 2014 Jun; 9(6):769-74. PubMed ID: 24787965 [TBL] [Abstract][Full Text] [Related]
50. Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer. Pekar-Zlotin M; Hirsch FR; Soussan-Gutman L; Ilouze M; Dvir A; Boyle T; Wynes M; Miller VA; Lipson D; Palmer GA; Ali SM; Dekel S; Brenner R; Bunn PA; Peled N Oncologist; 2015 Mar; 20(3):316-22. PubMed ID: 25721120 [TBL] [Abstract][Full Text] [Related]
51. Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma. Jang JS; Wang X; Vedell PT; Wen J; Zhang J; Ellison DW; Evans JM; Johnson SH; Yang P; Sukov WR; Oliveira AM; Vasmatzis G; Sun Z; Jen J; Yi ES J Thorac Oncol; 2016 Nov; 11(11):1891-1900. PubMed ID: 27343444 [TBL] [Abstract][Full Text] [Related]
52. On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas. Mescam-Mancini L; Lantuéjoul S; Moro-Sibilot D; Rouquette I; Souquet PJ; Audigier-Valette C; Sabourin JC; Decroisette C; Sakhri L; Brambilla E; McLeer-Florin A Lung Cancer; 2014 Feb; 83(2):168-73. PubMed ID: 24380695 [TBL] [Abstract][Full Text] [Related]
53. Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization. Wang W; Tang Y; Li J; Jiang L; Jiang Y; Su X Cancer Cytopathol; 2015 Feb; 123(2):117-22. PubMed ID: 25529354 [TBL] [Abstract][Full Text] [Related]
54. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing. Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552 [TBL] [Abstract][Full Text] [Related]
55. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance. Vollbrecht C; Lenze D; Hummel M; Lehmann A; Moebs M; Frost N; Jurmeister P; Schweizer L; Kellner U; Dietel M; von Laffert M BMC Cancer; 2018 Nov; 18(1):1158. PubMed ID: 30466405 [TBL] [Abstract][Full Text] [Related]
56. A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens. Lung J; Lin YC; Hung MS; Jiang YY; Lee KD; Lin PY; Tsai YH Lung Cancer; 2016 Apr; 94():114-20. PubMed ID: 26973216 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique. Nicoś M; Krawczyk P; Wojas-Krawczyk K; Bożyk A; Jarosz B; Sawicki M; Trojanowski T; Milanowski J Clin Transl Oncol; 2017 Dec; 19(12):1447-1453. PubMed ID: 28534101 [TBL] [Abstract][Full Text] [Related]
58. [Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases]. Fang F; Wang YX; Hu ST; Yang L; Di J; Liu DG; Lyu N Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):432-437. PubMed ID: 29886587 [No Abstract] [Full Text] [Related]
59. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment. Li W; Zhang J; Guo L; Chuai S; Shan L; Ying J J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248 [TBL] [Abstract][Full Text] [Related]
60. [Manual immunohistochemistry for detecting ALK gene fusion antibody in 519 cases of non-small lung cancer]. Gu X; Wu JY; He XM; He P; Fu XG; Lin YE; Li GQ; Hao Y Nan Fang Yi Ke Da Xue Xue Bao; 2015 Oct; 35(10):1440-5. PubMed ID: 26547338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]